COMPARE · Data as of August 24, 2026
BTSG vs OMCL
Verdict: Side-by-side breakdown using the Bull Rankings model. BTSG scored 54.6, OMCL scored 52.6 — BTSG leads.
Compare another set
BTSG
BrightSpring Health Services, Inc.
54.6
$59.49 · $11.8B
fundamentals as of
Score gap
2.0
BTSG leads
OMCL
Omnicell, Inc.
52.6
$34.66 · $1.6B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestOMCL42.3x
- Fastest growthBTSG+26.4%
- Strongest balance sheetOMCL0.15
- Highest qualityBTSG51 / 100
- Largest discount to fair valueOMCL-11%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
BTSG
stronger →← stronger
OMCL
51
Qualityreturns · margins · balance sheet
48
92
Growthrevenue & earnings expansion
59
35
Valuevaluation vs sector peers
51
BTSG is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
BTSG
OMCL
$402mC
FCF
$143mC
+26.4%A-
Rev
+8.5%B
1.16C
D/E
0.15B+
52.6xC
P/E
42.3xC
2.11C
PEG
15.40D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
BTSG
OMCL
114% above
Price vs fair valuelower is cheaper
11% below
~37%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-4%/yr
-64%
1-yr DCF upside
+25%
-53%
5-yr DCF upside
+13%
-34%
10-yr DCF upside
-3%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
BTSG
Why this score
- Diluting shareholders
- Short track record
OMCL
No notable signals flagged.
The companies
BTSGBrightSpring Health Services, Inc.
Why now
Health Information Services · market cap $11.8b. 19% off the 52-week high of $73.75. Revenue growing +26% — in hypergrowth territory. 17 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $78.94 (implying +33% upside).
Moat
ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 110% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 52.6x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Beta 1.88 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Net margin 2.5% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
OMCLOmnicell, Inc.
Why now
Health Information Services · market cap $1.6b. Down 37% from 52-week high of $55.00 — deep drawdown territory. 7 sell-side analysts publish a mean 1-yr target of $57.86 (implying +67% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 42x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where BTSG and OMCL diverge
On the headline score the gap is 2.0 points in favor of BTSG. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthBTSG 92.0 · OMCL 59.5BTSG +32.5
- ValueBTSG 35.0 · OMCL 51.4OMCL +16.4
- QualityBTSG 50.6 · OMCL 47.5BTSG +3.1
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.